ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 17: Congenital malformations and chromosomal abnormalitiesQ51

Q51

Non-billable

Congenital malformations of uterus and cervix

Chapter 17:Congenital malformations and chromosomal abnormalities

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 Q51 is a used to indicate a diagnosis of congenital malformations of uterus and cervix.

Key Diagnostic Point:

Congenital malformations of the uterus and cervix encompass a variety of structural abnormalities that are present at birth. These malformations can include conditions such as uterine agenesis, unicornuate uterus, and septate uterus, among others. The clinical significance of these conditions is profound, as they can lead to reproductive challenges, complications during pregnancy, and may necessitate surgical intervention. Understanding the specific type of malformation is crucial for developing an appropriate management plan and improving patient outcomes.

  • The coding for these conditions under the Q51 category is essential for accurate medical record-keeping and billing. Proper coding helps in tracking the prevalence of these congenital anomalies, guiding clinical research, and ensuring that patients receive the necessary care. Additionally, accurate documentation of these conditions can aid in the identification of potential genetic or environmental factors contributing to their occurrence, thus informing public health initiatives and preventive strategies.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in presentation
  • Need for detailed clinical documentation
  • Potential for surgical intervention

Audit Risk Factors

  • Inadequate documentation of specific malformations
  • Misclassification of related conditions
  • Failure to capture associated complications

Specialty Focus

Medical Specialties

Obstetrics and Gynecology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Reproductive Endocrinology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The clinical impact of the Q51 category is significant, as it directly relates to reproductive health and the management of congenital anomalies. Accurate coding can influence treatment decisions, patient counseling, and surgical planning, ultimately affecting patient outcomes. Additionally, the administrative impact includes the ability to track these conditions for research and public health purposes, which can lead to better understanding and management of congenital malformations.
On a broader scale, the implications for population health are notable, as identifying trends in congenital malformations can inform healthcare policies and preventive measures. As awareness of these conditions grows, healthcare systems can better allocate resources and support for affected individuals, improving overall quality of care.

ICD-9 vs ICD-10

The clinical impact of the Q51 category is significant, as it directly relates to reproductive health and the management of congenital anomalies. Accurate coding can influence treatment decisions, patient counseling, and surgical planning, ultimately affecting patient outcomes. Additionally, the administrative impact includes the ability to track these conditions for research and public health purposes, which can lead to better understanding and management of congenital malformations. On a broader scale, the implications for population health are notable, as identifying trends in congenital malformations can inform healthcare policies and preventive measures. As awareness of these conditions grows, healthcare systems can better allocate resources and support for affected individuals, improving overall quality of care.

Reimbursement & Billing Impact

reimbursement. Providers should ensure that all relevant diagnoses are accurately coded and that the medical necessity for any procedures is clearly documented. This includes providing evidence of the condition's impact on the patient's health and any treatments administered.

Resources

Clinical References

  • •
    Official ICD-10 Guidelines for Q51

Coding & Billing References

  • •
    Official ICD-10 Guidelines for Q51

Frequently Asked Questions

What conditions are included in Q51?

Q51 includes congenital malformations such as uterine agenesis, unicornuate uterus, septate uterus, and other structural abnormalities of the uterus and cervix.

When should I use Q51 codes?

Q51 codes should be used when a patient is diagnosed with a congenital malformation of the uterus or cervix, particularly when these conditions impact reproductive health or require surgical intervention.

What documentation is required for Q51?

Documentation should include the specific type of malformation diagnosed, any associated symptoms or complications, and details of any interventions or treatments provided.